Evidence map›Paper›PMID 25489633›Full record

ArticleEpilepsia2015

Pathogenic EFHC1 mutations are tolerated in healthy individuals dependent on reported ancestry.

Ryan L Subaran, Juliette M Conte, William C L Stewart, David A Greenberg

Open access · hybridAbstract read
In one paragraph

Article in Epilepsia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Involvement ofFrontiers in neurology · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Epilepsia open · 2017
    Article
  9. Article
  10. EFHC1 variants in juvenile myoclonic epilepsy: reanalysis according to NHGRI and ACMG guidelines for assigning disease causality.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ryan L SubaranNationwide Children's Hospital Research Institute, The Ohio State University, Columbus, Ohio, U.S.A.
Juliette M Conte
William C L Stewart
David A Greenberg
The Ohio State University · USColumbia University · USNationwide Children's Hospital · US

Funding

RESOLVING HETEROGENEITY IN EPILEPSY WITH GENETIC MARKERSR01NS027941 · NINDS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GREENBERG, DAVID A. · 1990 to 2010
$9.0M
Mechanisms of Genetic Seizure Susceptibility in Juvenile Myoclonic EpilepsyR01NS061829 · NINDS · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GREENBERG, DAVID A. · 2009 to 2012
$2.0M
The Role of Genome-Coded ME2 in EpilepsyR21NS070323 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GREENBERG, DAVID A. · 2009 to 2010
$798k
NINDS NIH HHS NS27941NINDS NIH HHS NS61829NINDS NIH HHS NS70323NINDS NIH HHS R01 NS027941NINDS NIH HHS R01 NS061829NINDS NIH HHS R21 NS070323
6 · The paper itself

Abstract

objectiveScreening for specific coding mutations in the EFHC1 gene has been proposed as a means of assessing susceptibility to juvenile myoclonic epilepsy (JME). To clarify the role of these mutations, especially those reported to be highly penetrant, we sought to measure the frequency of exonic EFHC1 mutations across multiple population samples.

methodsTo find and test variants of large effect, we sequenced all EFHC1 exons in 23 JME and 23 non-JME idiopathic generalized epilepsy (IGE) Hispanic patients, and 60 matched controls. We also genotyped specific EFHC1 variants in IGE cases and controls from multiple ethnic backgrounds, including 17 African American IGE patients, with 24 matched controls, and 92 Caucasian JME patients with 103 matched controls. These variants are reported to be pathogenic, but are also found among unphenotyped individuals in public databases. All subjects were from the New York City metro area and all controls were required to have no family history of seizures.

resultsWe found the reportedly pathogenic EFHC1 P77T-R221H (rs149055334-rs79761183) JME haplotype in one Hispanic control and in two African American controls. Public databases also show that the EFHC1 P77T-R221H JME haplotype is present in unphenotyped West African ancestry populations, and we show that it can be found at appreciable frequency in healthy individuals with no family history of epilepsy. We also found a novel splice-site mutation in a single Hispanic JME patient, the effect of which is unknown. SIGNIFICANCE: Our findings raise questions about the effect of reportedly pathogenic EFHC1 mutations on JME. One intriguing possibility is that some EFHC1 mutations may be pathogenic only when introduced into specific genetic backgrounds. By focusing on data from multiple populations, including the understudied Hispanic and Black/African American populations, our study highlights that for complex traits like JME, the body of evidence necessary to infer causality is high.

Indexed as

Genetic Predisposition to DiseaseAge of OnsetCalcium-Binding ProteinsEpilepsy, GeneralizedGenotypeHumansMutationMyoclonic Epilepsy, JuvenilePedigreeCalcium-Binding ProteinsEFHC1 protein, humanAncestry-specific effectsCausative genetic variantsComplex genetic disordersDisease predictionExonic variantsIdiopathic epilepsy

Identifiers

PMID25489633
PMCPMC4354299
OpenAlexW2001374270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.